California State Teachers Retirement System (CalSTRS)’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.04K | Buy |
+5,664
| New | +$8.04K | ﹤0.01% | 2809 |
|
|
2024
Q2 | – | Sell |
-6,982
| Closed | -$8.66K | – | 3087 |
|
|
2024
Q1 | $8.66K | Sell |
6,982
-48,577
| -87% | -$60.2K | ﹤0.01% | 2936 |
|
|
2023
Q4 | $58.3K | Sell |
55,559
-3,488
| -6% | -$3.66K | ﹤0.01% | 2560 |
|
|
2023
Q3 | $404K | Sell |
59,047
-8,054
| -12% | -$55.2K | ﹤0.01% | 2306 |
|
|
2023
Q2 | $696K | Buy |
67,101
+2,076
| +3% | +$21.5K | ﹤0.01% | 2132 |
|
|
2023
Q1 | $526K | Sell |
65,025
-1,299
| -2% | -$10.5K | ﹤0.01% | 2285 |
|
|
2022
Q4 | $1.04M | Buy |
66,324
+708
| +1% | +$11.2K | ﹤0.01% | 1866 |
|
|
2022
Q3 | $1.03M | Buy |
65,616
+3,618
| +6% | +$57K | ﹤0.01% | 1867 |
|
|
2022
Q2 | $865K | Buy |
61,998
+1,012
| +2% | +$14.1K | ﹤0.01% | 2056 |
|
|
2022
Q1 | $1.05M | Sell |
60,986
-5,474
| -8% | -$94.3K | ﹤0.01% | 2007 |
|
|
2021
Q4 | $966K | Buy |
66,460
+2,639
| +4% | +$38.4K | ﹤0.01% | 2180 |
|
|
2021
Q3 | $1.15M | Buy |
63,821
+3,925
| +7% | +$70.7K | ﹤0.01% | 2055 |
|
|
2021
Q2 | $1.05M | Buy |
+59,896
| New | +$1.05M | ﹤0.01% | 2185 |
|
|
2020
Q2 | – | Sell |
-47,336
| Closed | -$49K | – | 3020 |
|
|
2020
Q1 | $49K | Buy |
47,336
+549
| +1% | +$568 | ﹤0.01% | 2916 |
|
|
2019
Q4 | $88K | Sell |
46,787
-653
| -1% | -$1.23K | ﹤0.01% | 2938 |
|
|
2019
Q3 | $51K | Hold |
47,440
| – | – | ﹤0.01% | 2988 |
|
|
2019
Q2 | $104K | Sell |
47,440
-7,973
| -14% | -$17.5K | ﹤0.01% | 2977 |
|
|
2019
Q1 | $332K | Hold |
55,413
| – | – | ﹤0.01% | 2532 |
|
|
2018
Q4 | $410K | Buy |
55,413
+14,509
| +35% | +$107K | ﹤0.01% | 2404 |
|
|
2018
Q3 | $594K | Sell |
40,904
-3
| -0% | -$44 | ﹤0.01% | 2356 |
|
|
2018
Q2 | $817K | Buy |
40,907
+5,643
| +16% | +$113K | ﹤0.01% | 2180 |
|
|
2018
Q1 | $618K | Sell |
35,264
-1,381
| -4% | -$24.2K | ﹤0.01% | 2263 |
|
|
2017
Q4 | $904K | Buy |
36,645
+587
| +2% | +$14.5K | ﹤0.01% | 2060 |
|
|
2017
Q3 | $931K | Buy |
36,058
+362
| +1% | +$9.35K | ﹤0.01% | 2049 |
|
|
2017
Q2 | $968K | Buy |
35,696
+13,500
| +61% | +$366K | ﹤0.01% | 2082 |
|
|
2017
Q1 | $662K | Sell |
22,196
-1,100
| -5% | -$32.8K | ﹤0.01% | 2322 |
|
|
2016
Q4 | $632K | Buy |
23,296
+3,200
| +16% | +$86.8K | ﹤0.01% | 2392 |
|
|
2016
Q3 | $515K | Buy |
20,096
+1,200
| +6% | +$30.8K | ﹤0.01% | 2480 |
|
|
2016
Q2 | $349K | Buy |
18,896
+6,683
| +55% | +$123K | ﹤0.01% | 2664 |
|
|
2016
Q1 | $231K | Buy |
12,213
+1,563
| +15% | +$29.6K | ﹤0.01% | 2767 |
|
|
2015
Q4 | $287K | Buy |
+10,650
| New | +$287K | ﹤0.01% | 2730 |
|